Filters
New drug applications approved by US FDA as of 01-15 November 2021 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.
For many healthcare workers involved in palliative care, the intense emotions associated with end-of-life caregiving make them susceptible to a mental and physical fallout—a condition defined as burnout.